Fruquintinib
HMPL-013-SH-GC-101
Phase 2 small_molecule active
Quick answer
Fruquintinib for Stomach Neoplasms is a Phase 2 program (small_molecule) at RenJi Hospital with 1 ClinicalTrials.gov record(s).
Program details
- Company
- RenJi Hospital
- Indication
- Stomach Neoplasms
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active